What versions of gilteritinib are there?
gilteritinib is an anti-tumor drug used to treat acute myeloid leukemia (AML) caused by FLT3 gene mutations. Giritinib has been proven to be a feasible and effective drug in the treatment of leukemia.
There are multiple versions of giritinib, currently available as original drugs and generic drugs. Giritinib was developed byAstellas Pharma and was approved for marketing by the U.S.FDA in November 2019. Original medicines include American version, Chinese version, European version, Hong Kong version, Japanese version, Korean version, Taiwan version, etc. There are Lao versions of generic drugs. Lao Nanta Pharmaceutical produces generic drugs that are officially on the market and have government approval. Patients can choose drugs according to their own financial situation.
Gilatinib is an oral tablet. It is usually taken once daily for at least 6months. Gilatinib is taken at about the same time each day. an>, Carefully follow the instructions on the prescription label and ask your doctor to explain any part that the patient does not understand, Take GIRISTIB strictly as directed, Do not take more or less than the number prescribed by your doctor. When taking Swallow the tablets whole with water Do not cut, chew or crush them. The doctor may adjust the dose or stop treatment temporarily or permanently, depending on how well the drug works for the patient and if any side effects occur. If you feel well during the medication, you should continue to take gilitinib. Do not stop taking gilitinib by yourself. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)